Temozolomide Generics - Manufacturers & Suppliers
Temodar® (US & EU)
| Product/Composition:- | Temozolomide |
|---|---|
| Strength:- | Capsules: 5 mg, 20 mg, 100 mg, 140 mg; Tablets: 250 mg |
| Form:- | Oral Tablets and Oral Capsules |
| Reference Brands:- | Temodar® (US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Temozolomide (brand name Temodar®) is an oral chemotherapy used for glioblastoma multiforme (GBM) and anaplastic astrocytoma. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is approved in both the US and EU. Manufactured under GMP standards, Temozolomide is a key oncology treatment for global B2B pharmaceutical distribution.
Temozolomide is an oral chemotherapy agent used in the treatment of glioblastoma multiforme (GBM) and anaplastic astrocytoma, two aggressive brain cancers. Temozolomide works by damaging cancer cell DNA, preventing replication and inducing cell death. Available in 5 mg, 20 mg, 100 mg, 140 mg, and 250 mg strengths, it is marketed under the brand name Temodar® by Merck in both the US and EU. Manufactured under GMP-compliant facilities, it offers a reliable treatment option for oncology-focused pharmaceutical partners, providing a vital oral chemotherapy solution in the global cancer treatment market.